Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study-Reference-Cited by-同舟云学术

Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study

Published:2023-11-04 Issue:3 Volume:45 Page:233-235
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Long Xiangshu¹,Deng Shiyan¹,Liu Wei¹,Bu Jie¹,Chen Yaning¹,Tan Hongwen¹,Zheng Dan¹,Yu Shan¹,Liang Qin¹,Zhang Chenyun¹,Wu Qiang¹^ORCID

Affiliation:

1. Department of Cardiology, Guizhou Provincial People’s Hospital , 83 Zhongshan East Road , Guiyang 550002, China

Funder

Science Technology Platform

Talent Team Plan Projects of Guizhou Province

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/45/3/233/55676424/ehad741.pdf

Reference6 articles.

1. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines;Ommen;Circulation,2020

2. Acute and chronic effects of endocardial radiofrequency ablation of septal hypertrophy in HOCM;Lawrenz;J Cardiovasc Electrophysiol,2021

3. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy;Zhou;JAMA Cardiol,2022

4. Percutaneous transluminal radiofrequency closure of the coronary artery in animal studies;Zhang;Exp Ther Med,2013

5. Transcoronary radiofrequency ablation: a novel septal reduction option for hypertrophic obstructive cardiomyopathy;Wu;JACC Cardiovas Interv,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on interventional cardiology: the need for quality and transparency of evidence for implantable cardiovascular medical devices;European Heart Journal;2024-01-14